PubRank

Grant A Krafft

Author PubWeight™ 37.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002 5.63
2 Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 2004 5.10
3 Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A 2003 4.80
4 In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 2002 4.20
5 Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002 2.88
6 Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 2003 2.85
7 Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem 2006 2.32
8 Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 2007 2.25
9 Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J 2002 1.48
10 Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol 2010 1.34
11 Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J Biol Chem 2009 1.21
12 The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr Top Med Chem 2006 1.21
13 Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach. J Chem Phys 2008 1.02
14 The case for soluble Aβ oligomers as a drug target in Alzheimer's disease. Trends Pharmacol Sci 2013 1.00
15 Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease. Curr Alzheimer Res 2007 0.84